Literature DB >> 28193522

Intracerebroventricular injection of beta-amyloid in mice is associated with long-term cognitive impairment in the modified hole-board test.

Sebastian Schmid1, Bettina Jungwirth2, Verena Gehlert2, Manfred Blobner2, Gerhard Schneider2, Stephan Kratzer2, Kristine Kellermann2, Gerhard Rammes2.   

Abstract

BACKGROUND: The intracerebroventricular injection of beta-amyloid (Aβ) in mice allows the investigation of acute effects on cognitive function and cellular pathology. The aim of this investigation was to further characterize the time course of Aβ-induced cognitive and behavioural changes and to detect potential molecular mechanisms.
METHODS: Cannulas were implanted in the lateral cerebral ventricle. 14days after surgery the mice were injected with Aβ1-42 or phosphate buffered saline (PBS). Starting 2, 4 or 8 (PBS only 4) days after injection we evaluated cognitive and behavioural performance using the modified hole board test (mHBT). We determined tumour-necrosis factor alpha (TNF alpha) and caspase 3 by western blotting, on days 10, 12 and 16. Data were analysed using general linear modelling, Kruskall-Wallis and Mann-Whitney-U test.
RESULTS: Aβ induced a decline in cognitive performance represented as an increased total number of wrong choices during the testing period from day 2-15 (p<0.05). Behavioural parameters were comparable between mice treated with Aβ and PBS. There was no difference regarding TNF alpha levels between the groups. Compared to day 16 Caspase 3 levels were increased on day 10 (p=0.004).
CONCLUSIONS: Application of Aβ in the lateral ventricle of mice is associated with cognitive impairment of declarative memory in the mHBT. There is no interference caused by altered behaviour. Therefore, it represents a valid model for acute Aβ-mediated neurotoxic effects. Although the exact mechanisms remain unclear, changes in levels of Caspase 3 suggest apoptosis as an important factor for the development of cognitive dysfunction.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Beta-amyloid; Cognitive impairment; Intracerebroventricular injection; Modified hole-board test

Mesh:

Substances:

Year:  2017        PMID: 28193522     DOI: 10.1016/j.bbr.2017.02.007

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  9 in total

1.  Neural Stem Cells Secretome Increased Neurogenesis and Behavioral Performance and the Activation of Wnt/β-Catenin Signaling Pathway in Mouse Model of Alzheimer's Disease.

Authors:  Farzaneh Hijroudi; Reza Rahbarghazi; Saeed Sadigh-Eteghad; Gozal Bahlakeh; Mehdi Hassanpour; Mohammad Shimia; Mohammad Karimipour
Journal:  Neuromolecular Med       Date:  2022-05-16       Impact factor: 3.843

2.  Periodic Variation of AAK1 in an Aβ1-42-Induced Mouse Model of Alzheimer's Disease.

Authors:  Xue Fu; Meiling Ke; Weihua Yu; Xia Wang; Qian Xiao; Min Gu; Yang Lü
Journal:  J Mol Neurosci       Date:  2018-05-17       Impact factor: 3.444

3.  Preferential Neurodegeneration in the Dentate Gyrus by Amyloid β1-42-Induced Intracellular Zn2+Dysregulation and Its Defense Strategy.

Authors:  Haruna Tamano; Mako Takiguchi; Yukino Tanaka; Taku Murakami; Paul A Adlard; Ashley I Bush; Atsushi Takeda
Journal:  Mol Neurobiol       Date:  2019-12-21       Impact factor: 5.590

4.  Oleanolic Acid Ameliorates Aβ25-35 Injection-induced Memory Deficit in Alzheimer's Disease Model Rats by Maintaining Synaptic Plasticity.

Authors:  Kai Wang; Weiming Sun; Linlin Zhang; Wei Guo; Jiachun Xu; Shuang Liu; Zhen Zhou; Yulian Zhang
Journal:  CNS Neurol Disord Drug Targets       Date:  2018       Impact factor: 4.388

Review 5.  Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.

Authors:  Jelena Osmanovic Barilar; Ana Knezovic; Ana Babic Perhoc; Jan Homolak; Peter Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2020-02-06       Impact factor: 3.575

6.  Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer's disease.

Authors:  Zhengyu Li; Li Gan; Si Yan; Yufang Yan; Wei Huang
Journal:  Transl Neurosci       Date:  2020-05-29       Impact factor: 1.757

7.  Neurotoxicity of different amyloid beta subspecies in mice and their interaction with isoflurane anaesthesia.

Authors:  Laura Borgstedt; Manfred Blobner; Maximilian Musiol; Sebastian Bratke; Finn Syryca; Gerhard Rammes; Bettina Jungwirth; Sebastian Schmid
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

8.  Modified Huang-Lian-Jie-Du Decoction Ameliorates Aβ Synaptotoxicity in a Murine Model of Alzheimer's Disease.

Authors:  Yan Liu; Ting Du; Wenlong Zhang; Weiye Lu; Zhichao Peng; Shuqiong Huang; Xiangdong Sun; Xiaoqin Zhu; Chaojun Chen; Linchao Qian; Lei Wen; Pingyi Xu; Yunlong Zhang
Journal:  Oxid Med Cell Longev       Date:  2019-11-03       Impact factor: 6.543

9.  Nutrigenomic Studies on the Ameliorative Effect of Enzyme-Digested Phycocyanin in Alzheimer's Disease Model Mice.

Authors:  Yasuyuki Imai; Yurino Koseki; Makoto Hirano; Shin Nakamura
Journal:  Nutrients       Date:  2021-12-10       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.